Crizotinib in Patients With MET-Amplified NSCLC Article

ESI Most Cited Paper Industry Collaboration

cited authors

  • Camidge, D. Ross; Otterson, Gregory A.; Clark, Jeffrey W.; Ou, Sai-Hong Ignatius; Weiss, Jared; Ades, Steven; Shapiro, Geoffrey I.; Socinski, Mark A.; Murphy, Danielle A.; Conte, Umberto; Tang, Yiyun; Wang, Sherry C.; Wilner, Keith D.; Villaruz, Liza C.

authors

Publication Date

  • June 1, 2021

webpage

published in

category

keywords

  • Crizotinib
  • MET amplification
  • Next-generation sequencing
  • Non-small cell lung cancer
  • Oncogenic driver mutation

start page

  • 1017

end page

  • 1029

volume

  • 16

issue

  • 6